TAMISART

This brand name is authorized in Nigeria.

Active ingredients

The drug TAMISART contains one active pharmaceutical ingredient (API):

1
UNII U5SYW473RQ - TELMISARTAN
 

Telmisartan is an orally active and specific angiotensin II receptor (type AT1) antagonist. Telmisartan selectively binds the AT1 receptor. The binding is long-lasting.

 
Read more about Telmisartan

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-100642 Tablet TAMISART 80MG TABLETS TAB 80 mg 3x10 25 NF-PP-387177 TAMISART 80MG TABLETS TELMISARTAN 80MG TABLETS TELMISARTAN 80MG:EXCIPIENTS ( MICROCRYSTALLINE CELLULOSE PH, ,MEGLUMINE,SODIUM HYDROXIDE,PURIFIED WATER, PURIFIED WATER RINSING, MANNITOL, CROS PROVIDONE, SODIUM LAURYL SULPHATE, MAGNESIUM STEARATE. A4-100642 Drugs Imported Products 3X10 Prescription Only Medicine (POM) 11/15/2023 TAMAR & PHAREZ NIG LTD, NYERE STREET, NARAYI H/COST KADUNA KADUNA SOUTH KADUNA 8030524857 tamphar@gmail.com Maxtar Bio-genics, Khasra No.705, Village Malku Majra, Nalagarh Road Baddi Teh. Nalagarh, Pradesh, India 30/11/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
C09CA07 Telmisartan C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09C Angiotensin II antagonists, plain → C09CA Angiotensin II antagonists, plain
Discover more medicines within C09CA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-100642

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.